Cargando…
Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
The 1990s brought a burst of information regarding the structure, expression pattern, and role in leukocyte migration and adhesion of chemokines and their receptors. At that time, the FDA approved the first therapeutic antibodies for cancer treatment. A few years later, it was reported that the chem...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311683/ https://www.ncbi.nlm.nih.gov/pubmed/25688243 http://dx.doi.org/10.3389/fimmu.2015.00012 |